ATNM

Actinium Pharmaceuticals, Inc. ATNM

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ATNM AGEN AVXL RVPH AXSM TRAW TRVN GNPX CRVO
6M 23.85 % 138.24 % -2.71 % -7.29 % 23.55 % 45.00 % -98.94 % -27.20 % -5.71 %
YTD 27.78 % 31.07 % -29.05 % -68.88 % 38.74 % -66.55 % -99.25 % -78.47 % 258.97 %
1Y -8.52 % -14.38 % 59.33 % -49.15 % 41.83 % -42.12 % -99.39 % -43.24 % -41.78 %
3Y -79.09 % -92.15 % -21.42 % -83.92 % 162.17 % -83.43 % -99.99 % -99.64 % -7.88 %
5Y -84.75 % -95.49 % 93.27 % -94.20 % 60.27 % -97.73 % -100.00 % -99.88 % -87.44 %
10Y -97.58 % -95.55 % -3.36 % -93.56 % 1 286.16 % -100.00 % -100.00 % -99.90 % -99.99 %
From the beginning -96.42 % -99.95 % 7.75 % -93.56 % 1 286.16 % -100.00 % -100.00 % -99.90 % -100.00 %

Dividend